Skip to main content
Log in

Clinical evaluation of the anti-inflammatory effects of Heracleum persicum fruits

  • Brief Communication
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

Inflammation is a key player in the pathophysiology of atherosclerotic cardiovascular disease. Heracleum persicum Desf. Ex Fischer is a medicinal plant containing phytochemicals with anti-inflammatory activity. This study aimed to evaluate the anti-inflammatory effects of H. persicum extract in patients with minimal coronary artery disease. Subjects with <50 % luminal narrowing in any of the major coronary arteries in coronary angiography were randomly assigned to H. persicum fruit extract (n = 15; 300 mg/day) or placebo (n = 12) for 6 months. Serum concentrations of interleukin-6 (IL-6), interleukin-8 (IL-8), and C-reactive protein (CRP) were measured at baseline and at the end of study. Serum CRP levels were significantly reduced in both H. persicum (p = 0.007) and placebo (p = 0.035) groups by the end of trial. In contrast, no significant change in serum levels of IL-6 and IL-8 was observed in the study groups (p > 0.05). Comparison of the magnitude of changes between the study groups did not indicate any significant difference between H. persicum extract and placebo (p > 0.05). The present results did not indicate any superior effect of H. persicum to placebo in terms of changing serum levels of inflammatory biomarkers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Aynehchi Y, Aliabadi Z, Salehi Sormaghi MH (1987) Furanocoumarins in roots of Heracleum persisum Desf. Acta Horic 73:103–107

    Google Scholar 

  • Bose SK, Dewanjee S, Sahu R, Dey SP (2011) Effect of bergapten from Heracleum nepalense root on production of proinflammatory cytokines. Nat Prod Res 25:1444–1449

    Article  CAS  PubMed  Google Scholar 

  • Çoruh N, Celep AGS, Özgökçe F (2007) Antioxidant properties of Prangos ferulacea (L.) Lindl., Chaerophyllum macropodum Boiss. and Heracleum persicum Desf. from Apiaceae family used as food in Eastern Anatolia and their inhibitory effects on glutathione-S-transferase. Food Chem 100:1237–1242

    Article  Google Scholar 

  • Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Pariggiano I, et al (2014) Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep16: art. no. 435

  • Hajhashemi V, Sajjadi SE, Heshmati M (2009) Anti-inflammatory and analgesic properties of Heracleum persicum essential oil and hydroalcoholic extract in animal models. J Ethnopharmacol 124:475–480

    Article  CAS  PubMed  Google Scholar 

  • Kousha A, Bayat M (2012) Bactericidal and fungicidal activity of methanolic extracts of Heracleum persicum Desf. Ex Fischer against some aquatic and terrestrial animal pathogens. Int J Pharmacol 8:652–656

    Article  Google Scholar 

  • Libby P, Crea F (2010) Clinical implications of inflammation for cardiovascular primary prevention. Eur Heart J 31:777–783

    Article  CAS  PubMed  Google Scholar 

  • Merijanian A, Colasurdo I, Samtak P, Ullrichand J, Spagnuolo J (1980) The furanocoumarins of Heracleum persicum L. Rev Latinoam Quim 11:51–53

    CAS  Google Scholar 

  • Panahi Y, Pishgoo B, Beiraghdar F, Araghi ZM, Sahebkar A, Abolhasani E (2011) Results of a randomized, open-label, clinical trial investigating the effects of supplementation with Heracleum persicum extract as an adjunctive therapy for dyslipidemia. Sci World J 11:592–601

    Article  Google Scholar 

  • Pant S, Deshmukh A, Gurumurthy GS, Pothineni NV, Watts TE, Romeo F et al (2014) Inflammation and atherosclerosis—revisited. J Cardiovasc Pharmacol Ther 19:170–178

    Article  CAS  PubMed  Google Scholar 

  • Sahebkar A (2013) Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? BioFactors 39:197–208

    Article  CAS  PubMed  Google Scholar 

  • Sahebkar A, Watts GF (2013) New LDL-cholesterol lowering therapies: Pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin Ther 35:1082–1098

  • Sahebkar A, Chew GT, Watts GF (2014) Recent advances in pharmacotherapy for hypertriglyceridemia. Prog Lipid Res 56:47–66

    Article  CAS  PubMed  Google Scholar 

  • Sharififar F, Pournourmohammadi S, Arabnejad M, Rastegarianzadeh R, Ranjbaran O, Purhemmaty A (2009) Immunomodulatory activity of aqueous extract of Heracleum persicum Desf. in mice. Iran J Pharm Res 8:287–292

    CAS  Google Scholar 

  • Vasanthi HR, ShriShriMal N, Das DK (2012) Phytochemicals from plants to combat cardiovascular disease. Curr Med Chem 19:2242–2251

    Article  CAS  PubMed  Google Scholar 

  • Yang LL, Liang YC, Chang CW, Lee WS, Kuo CT, Wang CC et al (2002) Effects of sphondin, isolated from Heracleum laciniatum, on IL-1beta-induced cyclooxygenase-2 expression in human pulmonary epithelial cells. Life Sci 72:199–213

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amirhossein Sahebkar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Panahi, Y., Dadjo, Y., Pishgoo, B. et al. Clinical evaluation of the anti-inflammatory effects of Heracleum persicum fruits. Comp Clin Pathol 24, 971–974 (2015). https://doi.org/10.1007/s00580-015-2082-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-015-2082-3

Keywords

Navigation